Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Spdr S&p Biotech EtfETF ST STR SP BIOT | 397,505 | 404,505 | +7,000 | $35.80M | $32.81M | 9.30% | -$2.99M |
| Stereotaxis, Inc.(STXS) | 13,680,554 | 13,680,554 | 0 | $31.19M | $24.08M | 6.83% | -$7.11M |
| Revolution Medicines, Inc.(RVMD) | 631,176 | 656,176 | +25,000 | $27.61M | $23.20M | 6.58% | -$4.41M |
| Merus N V | 451,804 | 461,804 | +10,000 | $19.00M | $19.44M | 5.51% | +$439.0K |
| AtriCure, Inc.(ATRC) | 641,673 | 592,273 | -49,400 | $19.61M | $19.11M | 5.42% | -$502.8K |
| Cytokinetics, Incorporated(CYTK) | 398,100 | 398,100 | 0 | $18.73M | $16.00M | 4.54% | -$2.73M |
| Blueprint Medicines Corp | 149,763 | 152,263 | +2,500 | $13.06M | $13.48M | 3.82% | +$414.5K |
| Ishares Nasdaq Biotech IndxETF | 102,500 | 102,500 | 0 | $13.55M | $13.11M | 3.72% | -$441.8K |
| Axogen, Inc.(AXGN) | 846,882 | 680,782 | -166,100 | $13.96M | $12.59M | 3.57% | -$1.36M |
| Ascendis Pharma A/SADR(ASND) | 103,355 | 80,398 | -22,957 | $14.23M | $12.53M | 3.55% | -$1.70M |
| IDEAYA Biosciences, Inc.(IDYA) | 498,827 | 589,330 | +90,503 | $12.82M | $9.65M | 2.74% | -$3.17M |
| Xenon Pharmaceuticals Inc.(XENE) | 273,739 | 273,739 | 0 | $10.73M | $9.18M | 2.60% | -$1.55M |
| Kalvista Pharmaceuticals Inc | 811,678 | 752,359 | -59,319 | $6.87M | $8.68M | 2.46% | +$1.81M |
| Neurocrine Biosciences, Inc.(NBIX) | 71,615 | 71,615 | 0 | $9.78M | $7.92M | 2.25% | -$1.85M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 542,002 | 544,502 | +2,500 | $7.17M | $6.69M | 1.90% | -$476.1K |
| Day One Biopharmaceuticals I COM | 731,363 | 731,363 | 0 | $9.27M | $5.80M | 1.64% | -$3.47M |
| Tandem Diabetes Care, Inc.(TNDM) | 223,208 | 294,208 | +71,000 | $8.04M | $5.64M | 1.60% | -$2.40M |
| UroGen Pharma Ltd.(URGN) | 492,515 | 492,515 | 0 | $5.25M | $5.45M | 1.54% | +$201.9K |
| Biohaven Ltd.(BHVN) | 220,235 | 220,235 | 0 | $8.23M | $5.29M | 1.50% | -$2.93M |
| Mineralys Therapeutics, Inc.(MLYS) | 146,500 | 309,200 | +162,700 | $1.80M | $4.91M | 1.39% | +$3.11M |
| Arcus Biosciences, Inc.(RCUS) | 254,217 | 625,126 | +370,909 | $3.79M | $4.91M | 1.39% | +$1.12M |
| Ascendis Pharma A/SNOTE 2 250 4 0(ASND) | 0 | 0 | 0 | $4.41M | $4.71M | 1.34% | +$297.5K |
| DexCom, Inc.(DXCM) | 65,552 | 65,552 | 0 | $5.10M | $4.48M | 1.27% | -$621.4K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 667,000 | 558,255 | -108,745 | $5.02M | $4.19M | 1.19% | -$828.9K |
| Edgewise Therapeutics, Inc.(EWTX) | 187,140 | 183,140 | -4,000 | $5.00M | $4.03M | 1.14% | -$967.6K |
| Lakefront Biotherapeutics NVADR(LKFT) | 130,175 | 130,175 | 0 | $3.58M | $3.27M | 0.93% | -$309.8K |
| Inogen, Inc.(INGN) | 208,790 | 458,065 | +249,275 | $1.91M | $3.27M | 0.93% | +$1.35M |
| Insulet Corporation(PODD) | 12,400 | 11,900 | -500 | $3.24M | $3.13M | 0.89% | -$112.2K |
| Alkermes plcSHS(ALKS) | 120,700 | 94,200 | -26,500 | $3.47M | $3.11M | 0.88% | -$360.8K |
| Kura Oncology, Inc.(KURA) | 448,368 | 463,368 | +15,000 | $3.91M | $3.06M | 0.87% | -$847.1K |
| Stoke Therapeutics, Inc.(STOK) | 171,097 | 443,998 | +272,901 | $1.89M | $2.95M | 0.84% | +$1.07M |
| Immunovant, Inc.(IMVT) | 107,996 | 169,996 | +62,000 | $2.68M | $2.91M | 0.82% | +$230.2K |
| Bicara Therapeutics Inc | 105,500 | 212,001 | +106,501 | $1.84M | $2.76M | 0.78% | +$924.6K |
| Accuray Inc | 1,222,358 | 1,222,358 | 0 | $2.42M | $2.19M | 0.62% | -$232.2K |
| 2seventy Bio Inc | 429,252 | 429,252 | 0 | $1.26M | $2.12M | 0.60% | +$858.5K |
| Proqr Therapeutics N VSHS EURO SHS EURO | 1,567,561 | 1,567,561 | 0 | $4.15M | $2.08M | 0.59% | -$2.07M |
| COMPASS Pathways plcADS(CMPS) | 243,210 | 711,046 | +467,836 | $919.3K | $2.03M | 0.58% | +$1.11M |
| Allogene Therapeutics Inc | 1,240,118 | 1,380,118 | +140,000 | $2.64M | $2.01M | 0.57% | -$626.5K |
| TELA Bio, Inc.(TELA) | 1,441,029 | 1,441,029 | 0 | $4.35M | $1.76M | 0.50% | -$2.59M |
| Align Technology Inc | 5,500 | 11,000 | +5,500 | $1.15M | $1.75M | 0.50% | +$600.7K |
| Denali Therapeutics Inc.(DNLI) | 0 | 127,900 | +127,900 | $0 | $1.74M | 0.49% | +$1.74M |
| Astria Therapeutics Inc | 299,775 | 314,775 | +15,000 | $2.68M | $1.68M | 0.48% | -$999.1K |
| Viking Therapeutics, Inc.(VKTX) | 64,516 | 64,516 | 0 | $2.60M | $1.56M | 0.44% | -$1.04M |
| Regulus Therapeutics Inc | 875,200 | 847,176 | -28,024 | $1.38M | $1.48M | 0.42% | +$99.7K |
| BrainsWay Ltd.ADS(BWAY) | 193,208 | 156,533 | -36,675 | $1.82M | $1.48M | 0.42% | -$339.6K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 242,000 | +242,000 | $0 | $1.35M | 0.38% | +$1.35M |
| Keros Therapeutics, Inc.(KROS) | 130,316 | 130,316 | 0 | $2.06M | $1.33M | 0.38% | -$735.0K |
| Lexeo Therapeutics, Inc.(LXEO) | 393,083 | 378,083 | -15,000 | $2.59M | $1.31M | 0.37% | -$1.27M |
| Iteos Therapeutics Inc | 188,347 | 213,347 | +25,000 | $1.45M | $1.27M | 0.36% | -$172.8K |
| Palvella Therapeutics, Inc.(PVLA) | 71,452 | 43,348 | -28,104 | $857.4K | $1.21M | 0.34% | +$355.9K |
| ARS Pharmaceuticals, Inc.(SPRY) | 88,790 | 95,290 | +6,500 | $936.7K | $1.20M | 0.34% | +$262.0K |
| Lineage Cell Therapeutics, Inc.(LCTX) | 2,511,374 | 2,511,374 | 0 | $1.26M | $1.13M | 0.32% | -$127.8K |
| Alector Inc | 912,928 | 912,928 | 0 | $1.73M | $1.12M | 0.32% | -$602.5K |
| Foghorn Therapeutics Inc.(FHTX) | 186,717 | 304,752 | +118,035 | $881.3K | $1.11M | 0.32% | +$231.0K |
| Immatics N.V.SHS(IMTX) | 245,000 | 245,000 | 0 | $1.74M | $1.10M | 0.31% | -$637.0K |
| Structure Therapeutics IncADS | 35,500 | 59,000 | +23,500 | $962.8K | $1.02M | 0.29% | +$58.5K |
| Yarrow Bioscience Inc(YARW) | 0 | 636,103 | +636,103 | $0 | $1.01M | 0.28% | +$1.01M |
| MediWound Ltd.SHS NEW(MDWD) | 64,479 | 64,479 | 0 | $1.15M | $1.00M | 0.28% | -$147.0K |
| Gossamer Bio, Inc.(GOSS) | 1,409,262 | 907,854 | -501,408 | $1.27M | $998.6K | 0.28% | -$276.2K |
| BioNTech SEADS(BNTX) | 8,500 | 10,500 | +2,000 | $968.6K | $956.1K | 0.27% | -$12.4K |
| Autolus Therapeutics plcADS(AUTL) | 586,667 | 586,667 | 0 | $1.38M | $909.3K | 0.26% | -$469.3K |
| Sage Therapeutics Inc | 108,200 | 108,200 | 0 | $587.5K | $860.2K | 0.24% | +$272.7K |
| Korro Bio, Inc.(KRRO) | 0 | 47,086 | +47,086 | $0 | $819.8K | 0.23% | +$819.8K |
| Century Therapeutics, Inc.(IPSC) | 1,704,232 | 1,704,232 | 0 | $1.72M | $811.2K | 0.23% | -$910.1K |
| Larimar Therapeutics, Inc.(LRMR) | 371,434 | 371,434 | 0 | $1.44M | $798.6K | 0.23% | -$638.9K |
| PolyPid Ltd.(PYPD) | 291,273 | 291,273 | 0 | $885.5K | $789.4K | 0.22% | -$96.1K |
| Taysha Gene Therapies, Inc.(TSHA) | 522,500 | 522,500 | 0 | $903.9K | $726.3K | 0.21% | -$177.7K |
| Bicycle Therapeutics PlcADS | 120,799 | 80,799 | -40,000 | $1.69M | $686.0K | 0.19% | -$1.01M |
| Neurogene Inc.(NGNE) | 51,500 | 51,500 | 0 | $1.18M | $603.1K | 0.17% | -$574.2K |
| Cardiff Oncology, Inc.(CRDF) | 0 | 150,000 | +150,000 | $0 | $471.0K | 0.13% | +$471.0K |
| Erasca, Inc.(ERAS) | 0 | 340,000 | +340,000 | $0 | $465.8K | 0.13% | +$465.8K |
| InflaRx N.V.(IFRX) | 0 | 450,000 | +450,000 | $0 | $459.0K | 0.13% | +$459.0K |
| Adicet Bio Inc | 600,000 | 600,000 | 0 | $577.2K | $453.0K | 0.13% | -$124.2K |
| Aquestive Therapeutics Inc | 127,000 | 142,000 | +15,000 | $452.1K | $411.8K | 0.12% | -$40.3K |
| Compugen Ltd.(CGEN) | 447,202 | 272,402 | -174,800 | $684.2K | $397.7K | 0.11% | -$286.5K |
| ADC Therapeutics SASHS(ADCT) | 224,081 | 224,081 | 0 | $445.9K | $316.0K | 0.09% | -$130.0K |
| Sutro Biopharma, Inc.(STRO) | 437,079 | 437,079 | 0 | $804.2K | $284.4K | 0.08% | -$519.9K |
| Aprea Therapeutics, Inc.(APRE) | 137,174 | 137,174 | 0 | $451.3K | $279.8K | 0.08% | -$171.5K |
| Tessera Defense and Homeland Security Inc.(HLSQ) | 401,136 | 401,136 | 0 | $292.9K | $222.9K | 0.06% | -$70.0K |
| Nevro Corp | 38,000 | 38,000 | 0 | $141.4K | $221.9K | 0.06% | +$80.6K |
| Black Diamond Therapeutics I | 140,000 | 140,000 | 0 | $299.6K | $217.0K | 0.06% | -$82.6K |
| Spero Therapeutics, Inc.(SPRO) | 125,000 | 125,000 | 0 | $128.8K | $90.0K | 0.03% | -$38.8K |
| Tenaya Therapeutics, Inc.(TNYA) | 0 | 47,319 | +47,319 | $0 | $27.0K | 0.01% | +$27.0K |
| Acelyrin Inc | 87,989 | 0 | -87,989 | $276.3K | $0 | — | -$276.3K |
| Acrivon Therapeutics Inc | 112,414 | 0 | -112,414 | $676.7K | $0 | — | -$676.7K |
| Centessa Pharmaceuticals PlcADS | 47,453 | 0 | -47,453 | $794.8K | $0 | — | -$794.8K |
| Compass Therapeutics, Inc.(CMPX) | 158,394 | 0 | -158,394 | $229.7K | $0 | — | -$229.7K |
| Masimo Corp | 3,000 | 0 | -3,000 | $495.9K | $0 | — | -$495.9K |
| Perspective Therapeutics, Inc.(CATX) | 130,169 | 0 | -130,169 | $415.2K | $0 | — | -$415.2K |
| Vir Biotechnology, Inc.(VIR) | 100,000 | 0 | -100,000 | $734.0K | $0 | — | -$734.0K |